BOSCO, Raffaella
BOSCO, Raffaella
Dipartimento di Morfologia ed Embriologia (attivo dal 01/01/1998 al 30/09/2012)
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53 (mutated) B malignant cells.
file con accesso da definire2012 Bosco, Raffaella; Rabusin, M; Voltan, Rebecca; Celeghini, C; Corallini, Federica; Capitani, Silvano; Secchiero, Paola
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs
file con accesso da definire2010 Secchiero, Paola; Corallini, Federica; Castellino, Gabriella; Caruso, Lorenzo; Bugatti, S; Bosco, Raffaella; Montecucco, M; Trotta, Francesco; Bortoluzzi, Alessandra
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway.
file con accesso da definire2011 Zauli, Giorgio; Voltan, Rebecca; Bosco, Raffaella; Melloni, Elisabetta; Marmiroli, S; Rigolin, Gian Matteo; Cuneo, Antonio; Secchiero, Paola
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside.
file con accesso da definire2011 Bosco, Raffaella; Melloni, Elisabetta; Celeghini, C; Rimondi, Erika; Vaccarezza, M; Zauli, Giorgio
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts
file con accesso da definire2010 Secchiero, Paola; Zorzet, S; Tripodo, C; Corallini, Federica; Melloni, Elisabetta; Caruso, Lorenzo; Bosco, Raffaella; Ingrao, S; Zavan, B; Zauli, Giorgio
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells.
file con accesso da definire2011 Zauli, Giorgio; Voltan, Rebecca; DI IASIO, Maria Grazia; Bosco, Raffaella; Melloni, Elisabetta; Sana, Maria Elena; Secchiero, Paola
Molecular targets for selective killing of TRAIL-resistant leukemic cells.
file con accesso da definire2011 Zauli, Giorgio; Bosco, Raffaella; Secchiero, Paola
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells.
file con accesso da definire2011 Voltan, Rebecca; DI IASIO, Maria Grazia; Bosco, Raffaella; Valeri, N; Pekarski, Y; Tiribelli, M; Secchiero, Paola; Zauli, Giorgio
Recent advances in the therapeutic perspectives of Nutlin-3
file con accesso da definire2011 Secchiero, Paola; Bosco, Raffaella; Celeghini, C; Zauli, Giorgio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53 (mutated) B malignant cells. | 2012 | Bosco, Raffaella; Rabusin, M; Voltan, Rebecca; Celeghini, C; Corallini, Federica; Capitani, Silva...no; Secchiero, Paola | file con accesso da definire |
| Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs | 2010 | Secchiero, Paola; Corallini, Federica; Castellino, Gabriella; Caruso, Lorenzo; Bugatti, S; Bosco,... Raffaella; Montecucco, M; Trotta, Francesco; Bortoluzzi, Alessandra | file con accesso da definire |
| Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. | 2011 | Zauli, Giorgio; Voltan, Rebecca; Bosco, Raffaella; Melloni, Elisabetta; Marmiroli, S; Rigolin, Gi...an Matteo; Cuneo, Antonio; Secchiero, Paola | file con accesso da definire |
| Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. | 2011 | Bosco, Raffaella; Melloni, Elisabetta; Celeghini, C; Rimondi, Erika; Vaccarezza, M; Zauli, Giorgio | file con accesso da definire |
| Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts | 2010 | Secchiero, Paola; Zorzet, S; Tripodo, C; Corallini, Federica; Melloni, Elisabetta; Caruso, Lorenz...o; Bosco, Raffaella; Ingrao, S; Zavan, B; Zauli, Giorgio | file con accesso da definire |
| miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. | 2011 | Zauli, Giorgio; Voltan, Rebecca; DI IASIO, Maria Grazia; Bosco, Raffaella; Melloni, Elisabetta; S...ana, Maria Elena; Secchiero, Paola | file con accesso da definire |
| Molecular targets for selective killing of TRAIL-resistant leukemic cells. | 2011 | Zauli, Giorgio; Bosco, Raffaella; Secchiero, Paola | file con accesso da definire |
| Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. | 2011 | Voltan, Rebecca; DI IASIO, Maria Grazia; Bosco, Raffaella; Valeri, N; Pekarski, Y; Tiribelli, M; ...Secchiero, Paola; Zauli, Giorgio | file con accesso da definire |
| Recent advances in the therapeutic perspectives of Nutlin-3 | 2011 | Secchiero, Paola; Bosco, Raffaella; Celeghini, C; Zauli, Giorgio | file con accesso da definire |